Integrated Biopharma CFO Dina Masi's 2022 pay rises 12% to $300K
Integrated Biopharma reports 2022 executive compensation
By ExecPay News
Published: October 27, 2023
Integrated Biopharma reported fiscal year 2022 executive compensation information on October 27, 2023.
In 2022, five executives at Integrated Biopharma received on average a compensation package of $286K, a 12% increase compared to previous year.
Average pay of disclosed executives at Integrated Biopharma
Dina Masi, Chief Financial Officer, received $300K in total, which increased by 12% compared to 2021. 85% of Masi's compensation, or $254K, was in salary. Masi also received $37K in option awards and $9.6K in other compensation.
E. Gerald Kay, Chairman, received a compensation package of $286K. 75% of the compensation package, or $216K, was in salary.
E.Gerald Kay, Chairman, earned $286K in 2022, a 11% increase compared to previous year.
Riva Sheppard, Chief Executive Officer, received $278K in 2022, which increases by 14% compared to 2021.
Christina Kay, Chief Executive Officer, earned $276K in 2022, a 12% increase compared to previous year.
Integrated Biopharma's fiscal year ends on June 30.
Related executives
You may also like
Source: SEC filing on October 27, 2023.